| ISIN | CH0305280817 |
|---|---|
| Valor Number | 30528081 |
| Bloomberg Global ID | |
| Fund Name | BEKB Aktien Schweiz B |
| Fund Provider |
Berner Kantonalbank AG
Bern, Switzerland Phone: +41 31 666 11 11 E-Mail: bekb@bekb.ch Web: www.bekb.ch/fonds |
| Fund Provider | Berner Kantonalbank AG |
| Representative in Switzerland | |
| Distributor(s) |
Berner Kantonalbank Bern Phone: +41 31 666 11 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 149.34 CHF | 17.11.2025 |
|---|---|---|
| Previous Price * | 149.96 CHF | 14.11.2025 |
| 52 Week High * | 152.15 CHF | 12.11.2025 |
| 52 Week Low * | 127.46 CHF | 09.04.2025 |
| NAV * | 149.34 CHF | 17.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 548,977,987 | |
| Unit/Share Assets *** | 35,273,107 | |
| Trading Information SIX | ||
| YTD Performance | +9.39% |
31.12.2024 - 17.11.2025
31.12.2024 17.11.2025 |
|---|---|---|
| 1 month | -0.90% |
17.10.2025 - 17.11.2025
17.10.2025 17.11.2025 |
| 3 months | +2.34% |
18.08.2025 - 17.11.2025
18.08.2025 17.11.2025 |
| 6 months | +1.04% |
19.05.2025 - 17.11.2025
19.05.2025 17.11.2025 |
| 1 year | +8.40% |
18.11.2024 - 17.11.2025
18.11.2024 17.11.2025 |
| 2 years | +18.73% |
17.11.2023 - 17.11.2025
17.11.2023 17.11.2025 |
| 3 years | +21.25% |
17.11.2022 - 17.11.2025
17.11.2022 17.11.2025 |
| 5 years | +25.64% |
17.11.2020 - 17.11.2025
17.11.2020 17.11.2025 |
| Equity Participation Rate in % | 98.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 13.04% | |
|---|---|---|
| Nestle SA | 12.72% | |
| Roche Holding AG | 11.67% | |
| ABB Ltd | 6.42% | |
| UBS Group AG Registered Shares | 6.19% | |
| Zurich Insurance Group AG | 4.97% | |
| Compagnie Financiere Richemont SA Class A | 3.73% | |
| Lonza Group Ltd | 2.98% | |
| Holcim Ltd | 2.84% | |
| Givaudan SA | 2.24% | |
| Last data update | 31.10.2025 | |
| TER | 1.10% |
|---|---|
| TER date | 30.08.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |